SAV1 and renal carcinoma: Early evidence of a role for the Hippo pathway in cancer came from studies whereby the human orthologue of Salvador (SAV1), a founding member of the Drosophila Hippo pathway, were found to be mutated in renal cancer cell lines (Tapon et al, 2002).